- GlucoMe explores expansion for digital diabetes system
- Merck to acquire Peloton Therapeutics in a $1.05B deal
- Eisai brings Novartis executive on oncology board
- WuXi STA develops CDMO partnership with Dizal Pharma
- Sealed Air opens temperature assurance lab in Singapore
- Acutus Medical announces strategic acquisition & new partnerships in Monitoring and Therapy
- Novel technique reduces obstruction risk in heart valve replacement: NIH
- I Holland launches online training for pharmaceutical, nutraceutical professionals
- PolyPid gets a second QIDP designation for D-PLEX100
- Varian to acquire Cancer Treatment Services International for $283M
- Microsoft provides grant to develop Epilepsy prediction device
- WuXi Biologics signs vaccine manufacturing contract
- Merck joins TRANSVAC2 programme to advance vaccine development
- Takeda, Frazier Healthcare Partners to launch Phathom Pharma
-
China | 27 March 2019 | News
Hong Kong has the fourth-lowest health & well-being score, finds a Cigna survey
Global health service company Cigna Corporation has released the results of its 2019 Cigna 360 Well-Being Surv...Read more
India | 26 March 2019 | News
Study reveals majority cancer patients in India not getting right treatment
A study by Onco.com, the world’s first online cancer care platform, has come up with startling findings ...Read more
-
World | 21 May 2019 | News
I Holland launches online training for pharmaceutical, nutraceutical professionals
The introduction of technology enabled learning is helping companies improve the skills of their staff and is ...Read more
-
Australia | 20 May 2019 | News
Scientists find ‘molecular destruction code’ for enzyme involved in cholesterol production
A team of UNSW scientists at the School of Biotechnology and Biomolecular Sciences led by Professor Andrew Bro...Read more
-
China | 28 March 2019 | News
Medtronic launches MedTech innovation accelerator in Shanghai
Medtronic plc, the global leader in medical technology, has announced the launch of the Medtronic MedTech Inno...Read more
-
Malaysia | 27 March 2019 | News
Veeda Clinical Research successfully completes third inspection by NPRA
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmeda...Read more
3Ps augmenting drug discovery in APAC
Beyond meeting the needs of global pharma in simply providing access to patient pools and lower operational costs, the Asia-Pacific (APAC) region is also poised to realize the potential of a thriving biotechnology sector that is driving innovation on its own. APAC is gaining the experience and infrastructure needed to support the global biotech industry by performing work and fostering innovation through public private partnership (3Ps) that is moving up the pharmaceutical value chain.
